57
Growth Score in past quarter
pts
Heat Score 57 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1414119
Innovative anal-rectal pharmaceutical products
- Eran Eilat: Founder & CEOPast Role: Advanced Ophthalmic Pharma, CEO
About the Company
Peritech pharma is a specialty pharmaceuticals development company focusing on the anal-rectal area, targeting numerous indications with large markets and clear unmet medical needs.
Peritech Pharma is led by a team of seasoned professionals with over 50 years of combined experience in founding and managing startup companies in the life sciences
space, and including physicians, formulation developers, regulatory and IP experts as well as business professionals.
In June 2014 Peritech completed a clinical study comparing its lead OTC product (PP-110 for hemorrhoids) to a global leader in the field, with excellent results. The company is currently seeking partners for marketing this product.